Details for New Drug Application (NDA): 210118
✉ Email this page to a colleague
The generic ingredient in ICATIBANT ACETATE is icatibant acetate. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the icatibant acetate profile page.
Summary for 210118
Tradename: | ICATIBANT ACETATE |
Applicant: | Teva Pharms Usa |
Ingredient: | icatibant acetate |
Patents: | 0 |
Pharmacology for NDA: 210118
Mechanism of Action | Bradykinin B2 Receptor Antagonists |
Suppliers and Packaging for NDA: 210118
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 210118 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-3066 | 0093-3066-34 | 1 SYRINGE in 1 CARTON (0093-3066-34) / 3 mL in 1 SYRINGE |
ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 210118 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-3066 | 0093-3066-93 | 3 CARTON in 1 BOX (0093-3066-93) / 1 SYRINGE in 1 CARTON (0093-3066-19) / 3 mL in 1 SYRINGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | ||||
Approval Date: | Jul 15, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription